The forecast indicates an increasing trend in the number of top 10% cited scientific publications in infectious diseases in Canada with values climbing from 38.4 publications in 2024 to 39.85 in 2028. Assuming the base value for 2023 was slightly under 38 publications, the year-on-year growth rates for 2024 and 2025 are marginal, at approximately 1% and 0.9% respectively. The compound annual growth rate (CAGR) from 2024 to 2028 suggests an annual increase of about 0.9% over this period, reflecting steady but slow growth in research impact in this field.
Future trends to watch include potential shifts in publication dynamics due to advancements in technology, increased collaboration, and funding opportunities impacting the scale and impact of infectious disease research in Canada. Additionally, global health challenges may spur more groundbreaking work, enhancing Canada's academic contributions in this critical area.
